A Semiconducting Polymer Nano-prodrug for Hypoxia-Activated Photodynamic Cancer Therapy
Overview
Affiliations
Photodynamic therapy (PDT) holds great promise for cancer therapy; however, its efficacy is often compromised by tumor hypoxia. Herein, we report the synthesis of a semiconducting polymer nanoprodrug (SPNpd) that not only efficiently generates singlet oxygen ( O ) under NIR photoirradiation but also specifically activates its chemotherapeutic action in hypoxic tumor microenvironment. SPNpd is self-assembled from a amphiphilic polymer brush, which comprises a light-responsive photodynamic backbone grafted with poly(ethylene glycol) and conjugated with a chemodrug through hypoxia-cleavable linkers. The well-defined and compact nanostructure of SPNpd (30 nm) enables accumulation in the tumor of living mice. Owing to these features, SPNpd exerts synergistic photodynamic and chemo-therapy, and effectively inhibits tumor growth in a xenograft tumor mouse model. This study represents the first hypoxia-activatable phototherapeutic polymeric prodrug system with a high potential for cancer therapy.
Finely Tailored Conjugated Small Molecular Nanoparticles for Near-Infrared Biomedical Applications.
Li X, Zhang R, Yang Y, Huang W Research (Wash D C). 2025; 8():0534.
PMID: 39801503 PMC: 11717998. DOI: 10.34133/research.0534.
Hypoxia-tolerant polymeric photosensitizer prodrug for cancer photo-immunotherapy.
Yu J, Wu J, Huang J, Xu C, Xu M, Koh C Nat Commun. 2025; 16(1):153.
PMID: 39747121 PMC: 11695608. DOI: 10.1038/s41467-024-55529-8.
Sonodynamic and Acoustically Responsive Nanodrug Delivery System: Cancer Application.
Jeong Y, Park J, Khang D Int J Nanomedicine. 2024; 19:11767-11788.
PMID: 39553460 PMC: 11566213. DOI: 10.2147/IJN.S496028.
Strategies, Challenges, and Prospects of Nanoparticles in Gynecological Malignancies.
Zhang Y, Tian J ACS Omega. 2024; 9(36):37459-37504.
PMID: 39281920 PMC: 11391544. DOI: 10.1021/acsomega.4c04573.
Engineered photoresponsive biohybrids for tumor therapy.
Wang X, Sun Y, Wangpraseurt D Smart Med. 2024; 2(2):e20220041.
PMID: 39188274 PMC: 11235730. DOI: 10.1002/SMMD.20220041.